CD8A and melanoma: CD103+ CD8+ Trm cells play a solid protective role, and the long-term response of melanoma CD8+T cells to immunotherapy for more than one year can effectively prevent the reattack of melanoma; thus, CD103-dependent Trm cells play a crucial role in antitumor immunity (89).